Ortho Clinical Diagnostics Transfusion Medicine User Group Meeting

 

Our aim is to build upon our partnerships, bringing together members of the Transfusion Medicine community to share knowledge and expertise.

 

The meeting will comprise of presentations from the user community and Ortho staff members, including case studies, workflow analysis and open discussions as follows:

 

Opening: This will provide an update to the customer base on how Ortho is performing within the UK and share key messages/insights from the organisation in relation to the Transfusion Medicine community

 

Global Update: This will focus on how Ortho is performing at a Global level, and touch on future product launches and Software updates to the current portfolio.

 

Brexit: A look at the timeline of Brexit past, present and future.  Planning and preparedness for all possible outcomes, future implications on guidelines and the impact on diagnostics.

 

Update on Anti-D titration study: Phase I results and next steps.  An overview of the study to assess if titration, converted into a titre score, determined by the automated BioVue® column agglutination technology (CAT) is a comparable alternative to CFA to determine the nature of detected anti-D.

 

Case Study: Delayed and acute transfusion reactions.  Looking at two similar cases of patients admitted to A&E what happened, why, learnings and future investigations.  This will then lead to open forum discussions.

 

Implementation of Resolvigen – Users of the Resolvigen software describe the added benefits to the lab after its implementation.

 

Development of a protocol for a major haemorrhage pathway

 

Case study: Pathway of a patient with complex stem cell treatment describing from first-hand experience the pathway of patient who had to undergo complex stem cell treatment which resulted in her requiring blood transfusions as part of the treatment.

 

An emergency protocol for retaining blood services – contingency planning and maintaining a hospital transfusion service during an incident.  First hand experience and outcomes.

 

The value of genotyping in transfusion medicine – NEQAS presentation on the value and impact on transfusion medicine